Page 5 of 27, showing 20 records out of 533 total, starting on record 81, ending on 100
| Event |
Where |
When |
|
|
Annual Meeting of the Canadian Society of Endocrinology and Metabolism, Androgens and Antiandrogens in Clinical Endocrinology, “Inhibitors of Androgen Formation and Action in Prostatic Diseases”, Hali |
|
2000 |
|
|
Les Estrogènes; de la recherche à la pratique médicale (cancers hormono-dépendants et ménopause). « Les antiestrogènes purs », Marseilles (March 2000) |
|
2000 |
|
|
International Symposium on Prostate Cancer, National Cancer Institute, « Prostate Cancer Screening. Pros», Genova (March 2000) |
|
2000 |
|
|
American Chemical Society Meeting, Symposium on Selective Estrogen Receptor Modulators, "EM-652 (SCH-57068): First Pure Response-Specific ER Regulator (Pure SERR) having Activities Ranging from Pure A |
|
2000 |
|
|
NIH Endocrine Rounds, Endocrinology and Hormone-Sensitive Cancers and Menopause (March 2000) |
|
2000 |
|
|
8th World Congress of Gynecological Endocrinology, « DHEA Replacement Therapy as Source of Androgens and Estrogens at Menopause » Florence (December 2000) |
|
2000 |
|
|
Aromatase 2000 and the Third Generation, “EM-652/SCH-57068: a Unique SERM having Pure Antiestrogenic Activity in the Mammary Gland and Endometrium”, Port Douglas, Australia (November 2000) |
|
2000 |
|
|
2000 Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism Annual Meeting, “Androgens and Antiandrogens in Clinical Endocrinology – Strategies to Block the Formation and Actio |
|
2000 |
|
|
3rd Teupitz Colloquium on Basic Research in Endocrine Dermatology, “Endocrine Dermatology” “Intracrinology in the Skin”, Berlin (September 2000) |
|
2000 |
|
|
Second International Symposium on Signal Transduction in Health and Disease (STADY II), GnRH Analogs in Reproduction and Cancer », « The Crucial Role of GnRH Analogues in the Prolongation of Survival |
|
2000 |
|
|
82nd Annual Meeting of the US Endocrine Society, CMES Ancillary Symposium “Beyond Receptors : The Emerging Role of Enzyme Modulators”, « The Intracrine Concept and Tissue-Specific Response », “Intracr |
|
2000 |
|
|
7th World Congress of Gynecological Endocrinology "Genomic and Non-Genomic Steroid Hormone Effects", "Potential of DHEA as Hormone Replacement Therapy at Menopause", Buenos Aires (April 1999) |
|
1999 |
|
|
7th World Congress of Gynecological Endocrinology "Endocrine Aspects Involving the Hypothalamo-Pituitary Adrenal Axis", "Intracrinology: its Role in Human Disease", Buenos Aires (April 1999) |
|
1999 |
|
|
The Royal Society of Medicine: Section of Urology and the British Prostate Group, "The Impact of Basic Science on Screening, Treatment and Quality of Life - the Quebec Screening Study ", London (April |
|
1999 |
|
|
Ninth International Congress on Anticancer Treatment, "Update on Combined Androgen Blockade", Paris (February 1999) |
|
1999 |
|
|
10th World Congress on Human Reproduction, "Potential of DHEA as Hormone Replacement Therapy", Salvador de Bahia, Brazil (May 1999) |
|
1999 |
|
|
Opening Conference, 28e Congrès de l'Association des Archivistes du Québec, "Rôle de la recherche dans la qualité des soins de santé", Québec (June 1999) |
|
1999 |
|
|
2nd International Consultation on Prostate Cancer, World Health Organization, International Union Against Cancer, "Management of Newly Diagnosed Metastatic Prostate Cancer", Paris (June 1999) |
|
1999 |
|
|
9th International World Congress on the Menopause, International Menopause Society, "Mechanisms of Sex Steroid Formation and Action", Yokohama, Japan (October 1999) |
|
1999 |
|
|
National Oncology Forum, NCI, “PSA Screening: Decrease in Mortality Rate”, Chicago (October 1999) |
|
1999 |
|